| Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| CGEM | Cullinan Oncology, Inc. | Savill Corrine | Chief Business Officer | Feb 01, 2024 | Option Exercise | $10.24 | 80,000 | 819,200 | 205,990 | Feb 02, 2024, 09:35 PM | |
| CGEM | Cullinan Oncology, Inc. | Savill Corrine | Chief Business Officer | Jan 29, 2024 | Option Exercise | $9.20 | 80,000 | 735,600 | 205,990 | Jan 30, 2024, 07:00 PM | |
| CGEM | Cullinan Oncology, Inc. | Savill Corrine | Chief Business Officer | Jan 22, 2024 | Sale | $8.71 | 33,243 | 289,515 | 184,674 | Jan 24, 2024, 05:00 PM | |
| CGEM | Cullinan Oncology, Inc. | Savill Corrine | Chief Business Officer | Jan 23, 2024 | Option Exercise | $8.38 | 42,632 | 357,256 | 187,306 | Jan 24, 2024, 05:00 PM | |
| CGEM | Cullinan Oncology, Inc. | Savill Corrine | Acting Chief Business Officer | Jul 18, 2022 | Sale | $15.06 | 5,042 | 75,933 | 164,573 | Jul 21, 2022, 04:30 PM | |
| CGEM | Cullinan Oncology, Inc. | Savill Corrine | Acting Chief Business Officer | Jul 19, 2022 | Sale | $15.22 | 14,958 | 227,661 | 149,615 | Jul 21, 2022, 04:30 PM | |
| CGEM | Cullinan Oncology, Inc. | Savill Corrine | Acting Chief Business Officer | Jul 11, 2022 | Sale | $13.33 | 40,000 | 533,304 | 169,815 | Jul 12, 2022, 04:14 PM |
Menu